Microcosm Epoch has secured millions in Pre-A financing led by Kunlun Capital to advance its quantum computing applications in the biomedical and materials sectors.
Information on the Target
Microcosm Epoch, a pioneering company in quantum computing applications, has recently announced the completion of a Pre-A round financing, raising millions of yuan. This funding round was co-led by Kunlun Capital and Hefei High-Tech Investment. Established in February 2022, Microcosm Epoch aims to address critical challenges in the national quantum computing industry by bridging gaps and advancing the application of quantum technologies in various sectors.
The company specializes in utilizing core technologies, such as quantum chemistry simulations and quantum optimization algorithms, to innovate drug discovery and new materials design. Their efforts expedite the development of new drugs and materials while optimizing associated costs and timelines. The core team, primarily comprised of graduates from the University of Science and Technology of China (USTC) Young Talents Program, brings diverse expertise in biology, chemistry, and artificial intelligence, collaborating with top domestic universities and research institutions to enhance their research and development capabilities.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in China
China's quantum computing industry is recognized for its rapid advancements and research output, positioning itself among global leaders. In recent years, the Chinese government has prioritized investments in quantum research, accelerating the
Similar Deals
Qiming Venture Partners → Iongen Therapeutics Co., Ltd.
2025
昆仑资本
invested in
微观纪元
in 2024
in a Pre-Seed Stage deal
Disclosed details
Transaction Size: $5M